DTaP-IPV/Hib Vaccine Primary & Booster Vaccinations Versus Co-administration of DTaP-IPV and Hib Vaccine in Japanese Infants

Clinical trial NCT02274285 · COMPLETED

Trial details

NCT number: NCT02274285
Sponsor: Sanofi Pasteur, a Sanofi Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Tetanus Diphtheria Pertussis Poliomyelitis Bacterial Meningitis

Start date: 2014-10-01
Primary completion: 2016-05-28
Enrollment: 424

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.